This inventor holds 2 USPTO granted patents and 10 published patent applications and 1 EPO patent. Top assignees: Boehringer Ingelheim Io Canada Inc., Nectin Therapeutics Ltd.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Arif Jetha: Innovator in Antibody Research
Introduction
Arif Jetha is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of antibody therapies. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Arif Jetha holds a patent for "FLT3 Agonist Antibodies and Uses Thereof." This innovative patent reflects his expertise in creating therapeutic antibodies that target specific pathways in cancer treatment. His work in this area is crucial for developing new treatment options for patients.
Career Highlights
Arif Jetha is currently employed at Boehringer Ingelheim (Canada) Inc., where he continues to push the boundaries of research and development in biotechnology. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking projects.
Collaborations
Throughout his career, Arif has worked alongside talented colleagues, including Phil Gobeil and Melissa Beilschmidt. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their shared research interests.
Conclusion
Arif Jetha is a dedicated inventor whose work in antibody research is making a significant impact in the field of biotechnology. His contributions, particularly through his patent, highlight the importance of innovation in developing new therapies for patients.